Hasil Pencarian - Parodi A
- Menampilkan 1 - 9 hasil dari 9
-
1
IL-1 beta receptor antagonist efficacy in the treatment of idiopathic recurrent pericarditis oleh Picco P, Traverso F, Brisca G, Parodi A, Loy A, Gattorno M, Martini A
Diterbitkan 2008-09-01Artikel -
2
Effects of the protein corona on liposome–liposome and liposome–cell interactions oleh Corbo C, Molinaro R, Taraballi F, Toledano Furman NE, Sherman MB, Parodi A, Salvatore F, Tasciotti E
Diterbitkan 2016-07-01Dapatkan teks lengkap
Artikel -
3
-
4
Comparison of physician's, parent's and patient's global ratings made on linear or 21-circle visual analogue scales (VAS) in juvenile idiopathic arthritis (JIA) oleh Dalprà S, Verazza S, Ferrari C, Parodi A, Davì S, Schiappapietra B, Consolaro A, Filocamo G, Viola S, Martini A, Ravelli A
Diterbitkan 2008-09-01Artikel -
5
Etanercept efficacy in the treatment of chronic isolated inflammatory coxitis oleh Parodi A, Picco P, Malattia C, Davì S, Dalprà S, Traverso F, Ponti MC, Buoncompagni A, Loy A, Viola S, Martini A
Diterbitkan 2008-09-01Artikel -
6
Quantitative assessment of synovitis in juvenile idiopathic arthritis using Dynamic Contrast-Enhanced Magnetic Resonance Imaging oleh Malattia C, Damasio MB, Basso C, Verri A, Magnaguagno F, Parodi A, Viola S, Ravelli A, Tomà P, Martini A
Diterbitkan 2008-09-01Artikel -
7
The diagnostic role of hyperferritinemia in a tertiary care pediatric rheumatology setting oleh Sala I, Trail L, Lattanzi B, Solari N, Palmisani E, Parodi A, Malattia C, Buoncompagni A, Loy A, Martini A, Ravelli A
Diterbitkan 2008-09-01Artikel -
8
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study oleh Talamonti M, Russo F, Malara G, Hansel K, Papini M, Cattaneo A, Parodi A, Chiricozzi A, Malagoli P, Bardazzi F, Brazzelli V, Dapavo P, Gisondi P, Zane C, Potenza C, Cantoresi F, Fargnoli MC, Trevisini S, Brianti P, Pescitelli L, Gigante G, Bartezaghi M, Caputo L, Aloisi E, Costanzo A
Diterbitkan 2023-04-01Dapatkan teks lengkap
Artikel -
9
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study oleh Russo F, Galluzzo M, Stingeni L, Persechino S, Zichichi L, Conti A, Giofrè C, Dini V, Vispi M, Atzori L, Cattaneo A, Parodi A, Bardazzi F, Stinco G, Dapavo P, Girolomoni G, Musumeci ML, Papini M, Venturini M, Dastoli S, Di Nuzzo S, Fargnoli MC, Pagnanelli G, Bernardini N, Gambini DM, Malagoli P, Mazzatenta C, Peris K, Zalaudek I, Fabbrocini G, Loconsole F, Vassallo C, Pietroleonardo L, Prignano F, Franchi C, Offidani AM, Bonifati C, Di Lernia V, Gigante G, Bartezaghi MS, Franchi M, Ursoleo P, Aloisi E
Diterbitkan 2023-12-01Dapatkan teks lengkap
Artikel